Dr. Matthew L. Ryan
Claim this profileSaint Vincent Hospital Cancer Center Green Bay
Studies Breast Cancer
Studies Lung Cancer
53 reported clinical trials
120 drugs studied
About Matthew L. Ryan
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Internal Medicine at a hospital affiliated with the University of Wisconsin School of Medicine and Public Health.
- Undertook a Fellowship in Hematology/Oncology at the University of Wisconsin Carbone Cancer Center.
Experience:
- Currently practices as a hematologist and oncologist at Saint Vincent Hospital Cancer Center in Green Bay.
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
ER positive
2Lung Cancer
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Matthew L. Ryan is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Matthew L. Ryan
Clinical Trial Related2 years of experience running clinical trials · Led 53 trials as a Principal Investigator · 25 Active Clinical TrialsTreatments Matthew L. Ryan has experience with
- Atezolizumab
- Paclitaxel
- Cisplatin
- Docetaxel
- Pembrolizumab
- Nivolumab
Breakdown of trials Matthew L. Ryan has run
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew L. Ryan specialize in?
Matthew L. Ryan focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Matthew L. Ryan currently recruiting for clinical trials?
Yes, Matthew L. Ryan is currently recruiting for 25 clinical trials in Green Bay Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Matthew L. Ryan has studied deeply?
Yes, Matthew L. Ryan has studied treatments such as Atezolizumab, Paclitaxel, Cisplatin.
What is the best way to schedule an appointment with Matthew L. Ryan?
Apply for one of the trials that Matthew L. Ryan is conducting.
What is the office address of Matthew L. Ryan?
The office of Matthew L. Ryan is located at: Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin 54301 United States. This is the address for their practice at the Saint Vincent Hospital Cancer Center Green Bay.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.